{
  "Variants Include": [
    {
      "Gene": "PARKIN",
      "variants": [
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "A",
            "alt": "G",
            "position": "48"
          },
          "Protein Change": {
            "ref": "K",
            "alt": "A",
            "position": "48"
          },
          "Description in input context": "K48A (p.K48A)"
        },
        {
          "HGVS": "N.D.",
          "cDNA Change": {
            "transcript": "N.D.",
            "ref": "C",
            "alt": "C",
            "position": "42"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "P",
            "position": "42"
          },
          "Description in input context": "R42P (p.R42P)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Autosomal recessive juvenile Parkinson's disease",
    "MONDO": "N.D."
  },
  "Experiment Method": [
    {
      "Assay Method": "Urea unfolding experiments",
      "Material used": {
        "Material Source": "Recombinant protein",
        "Material Name": "Parkin Ubiquitin-like domain (Ubld) and ubiquitin",
        "Description": "The study utilized recombinant parkin Ubld and ubiquitin to assess structural stability."
      },
      "Readout type": "Quantitative (protein stability measurements)",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "Normal",
          "Molecular Effect": "No significant impact on stability",
          "Result Description": "K48A mutation had minimal effect on protein stability."
        },
        {
          "Variant": "N.D.",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Loss of structural integrity",
          "Result Description": "R42P mutation caused complete unfolding of the protein."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type parkin Ubld was used as a control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Ubiquitin was used as a control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": 0
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": 0
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "N.D."
      }
    },
    {
      "Assay Method": "NMR spectroscopy",
      "Material used": {
        "Material Source": "Recombinant protein",
        "Material Name": "Parkin Ubld",
        "Description": "NMR spectroscopy was used to analyze structural changes in parkin Ubld."
      },
      "Readout type": "Qualitative (structural analysis)",
      "Readout description": [
        {
          "Variant": "N.D.",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Disrupted secondary structure",
          "Result Description": "R42P mutation led to loss of secondary structure in parkin Ubld."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type parkin Ubld was used as a control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Ubiquitin was used as a control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": 0
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": 0
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "N.D."
      }
    }
  ]
}